[Attention-getting sexually transmitted diseases: Hepatitis B].
Takahashi
Shoichi
S
Chayama
Kazuaki
K
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000241:Adenosine / Q000031:analogs & derivatives; D000998:Antiviral Agents / Q000627:therapeutic use; D015897:Comorbidity; D004359:Drug Therapy, Combination; D005838:Genotype; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006151:Guanosine / Q000031:analogs & derivatives; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy / Q000635:transmission / Q000821:virology; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015229:Sexually Transmitted Diseases, Viral
D000998:Antiviral Agents; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D006151:Guanosine; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; C053001:adefovir; D000225:Adenine; D000241:Adenosine